| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 07/28/2005 | DE4243381B4 3(2H)-Pyridazinonderivate, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie diese enthaltende Arzneimittel und ihre Verwendung 3 (2H) -pyridazinone derivatives, processes and intermediates for their preparation and pharmaceutical compositions containing them and their use |
| 07/28/2005 | CA2554382A1 Compounds useful in therapy |
| 07/28/2005 | CA2552953A1 Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors |
| 07/28/2005 | CA2552681A1 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d) (1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system |
| 07/28/2005 | CA2552403A1 Benzimidazole derivatives |
| 07/28/2005 | CA2551770A1 2, 4 - diaminopyrimidines and their use for inducing cardiomyogenesis |
| 07/28/2005 | CA2551639A1 (3-oxo-3, 4-dihydro-quinoxalin-2-yl-amino) -benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity |
| 07/27/2005 | EP1557416A1 Oxazolidinone-quinolone hybrid antibiotics |
| 07/27/2005 | EP1557410A2 Bacterial gyrase inhibitors and uses thereof |
| 07/27/2005 | EP1556445A2 Metal complexes as light-absorbing compounds in the information layer of optical data carriers |
| 07/27/2005 | EP1556356A1 Tetrahydroquinoline derivatives as crth2 antagonists |
| 07/27/2005 | EP1556349A1 1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors |
| 07/27/2005 | EP1556049A1 Piperidine-pyridazones and phthalazones as pde4 inhibitors |
| 07/27/2005 | EP1556047A2 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 07/27/2005 | EP1556046A1 Phenylpiperidines and phenylpyrrolidines as histamine h3 receptor modulators |
| 07/27/2005 | EP1556039A2 Process for the preparation of tri-nitrogen containing heteroaryl-diamine derivatives useful as pharmaceutical agents and methods of producing pharmaceutical agents |
| 07/27/2005 | EP1556032A1 Agent for preventing or treating neuropathy |
| 07/27/2005 | EP1556030A2 Taxane metabolites |
| 07/27/2005 | EP1047418B1 Inhibition of raf kinase using substituted heterocyclic ureas |
| 07/27/2005 | CN1646525A Process for 5-[[2(R)-[1(R)-[3, 5-bis(trifluoromethyl)phenyl]ethoxy]-3(S)-(4-fluorophenyl)-4-morpholinyl]methyl]-1, 2-dihydro-3H-1, 2, 4-triazol-3-one |
| 07/27/2005 | CN1646523A Substituted 4-pyrazolyl pyrazolines used for pest control |
| 07/27/2005 | CN1646512A A semi-synthetic process for the preparation of N debenzoylpaclitaxel |
| 07/27/2005 | CN1646505A Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 07/27/2005 | CN1646504A Substituted benzoxazoles and analogues as estrogenic agents |
| 07/27/2005 | CN1646502A Triazole derivatives as tachykinin receptor antagonists |
| 07/27/2005 | CN1646497A New aryl imidazoles and related compounds as C5a receptor modulators |
| 07/27/2005 | CN1646489A Delta1-pyrrolines and their use as pestcidal |
| 07/27/2005 | CN1646446A Non-heating clay composites for building materials |
| 07/26/2005 | US6921821 Antagonists of melanin concentrating hormone receptor |
| 07/26/2005 | US6921767 Such as (2-(4-(3-(1,4,5,6-Tetrahydropyrimidin-2-ylamino)prop oxy)phenyl) -cyclopropyl)acetic acid; for treating angiogenesis/osteoporosis/ humoral hypercalcemia/smooth muscle cell migration/atherosclerosis/arthritis |
| 07/26/2005 | US6921760 Psychotherapeutic agents. |
| 07/26/2005 | CA2193388C Aryl and heteroaryl alkoxynaphthalene derivatives |
| 07/21/2005 | WO2005066165A1 N-substituted piperidine and piperazine derivatives |
| 07/21/2005 | WO2005066164A1 Opioid receptor antagonists |
| 07/21/2005 | WO2005066163A2 Thiophene derivatives as chk 1 inihibitors |
| 07/21/2005 | WO2005066159A1 Cathepsin cysteine protease inhibitors |
| 07/21/2005 | WO2005066156A1 Selective kinase inhibitors |
| 07/21/2005 | WO2005066153A1 Tricyclic steroid hormone nuclear receptor modulators |
| 07/21/2005 | WO2005066151A2 Histone deacetylase inhibitors |
| 07/21/2005 | WO2005066137A1 2,5-diaryl-1h-imidazole-4-carboxamides as neurokinin-3 receptor modulators for the treatment of central nervous system and peripheral diseases |
| 07/21/2005 | WO2005065779A1 Calcitonin gene related peptide receptor antagonists |
| 07/21/2005 | WO2005065050A2 Bicyclic compound |
| 07/21/2005 | WO2005042497A3 Benzimidazoles useful as modulators of ion channels |
| 07/21/2005 | WO2005013914A3 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 07/21/2005 | WO2004087051A3 Ophthalmic compositions for treating ocular hypertension |
| 07/21/2005 | US20050159603 For arachnids and nematodes |
| 07/21/2005 | US20050159599 Insecticides for soil/seed treatment |
| 07/21/2005 | US20050159598 Activators of human peroxisome proliferator activated receptors such as {2-[2-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl}methanol |
| 07/21/2005 | US20050159475 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate |
| 07/21/2005 | US20050159469 HIV protease inhibiting compounds |
| 07/21/2005 | US20050159466 Production method of isoxazolidinedione compound |
| 07/21/2005 | US20050159463 5-methoxy-3-(2-(2-furamido) ethyl)indole; related to melatonin, but pharmacologicaly and pharmacokineticy different; longer duration, selective localization and greater efficacy |
| 07/21/2005 | US20050159462 Elevates extracellular adenosine concentration for antiinflammatory and immunosuppressive effects; reaction of imidazole-4-carboxamide with a hydroxyalkylbenzoxazole or benzothiazole compound; 1-[4-hydroxy-1-(2-phenyl-4-benzoxazolyl)-3-pentyl]-imidazole-4-carboxamide |
| 07/21/2005 | US20050159455 1,4-dihydropyridine and pyridine compounds as calcium channel blockers |
| 07/21/2005 | US20050159452 Nociceptin analogs |
| 07/21/2005 | US20050159446 of preparing 4-substituted quinoline compounds as intermediates in the manufacture of receptor tyrosine kinase inhibitors and intermediate compounds used in the methods thereof, wherein the 4-substituted quinoline compound has the following general formula (I): |
| 07/21/2005 | US20050159435 [3-Methyl-4-(pyridin-3-yloxy)-phenyl]-(6-piperidin-3-ylethynyl-quinazolin-4-yl)-amine; selective inhibitors of receptor tyrosine kinases and non-receptor tyrosine kinases (eg: Ick, src, abl) or serine/threonine kinases (e.g.: cyclin dependent kinases); carcinoma |
| 07/21/2005 | US20050159427 N-acylsulfonamide apoptosis promoters |
| 07/21/2005 | US20050159424 pharmaceutically-acceptable salts, prodrugs, solvates, isomers, and/or hydrates thereof, wherein Q is an optionally-substituted phenyl, pyridyl, pyridazinyl, pyrimidinyl, or pyrazinyl ring; R2 is alkyl or an amino group as defined herein; and Z is optionally-substituted oxadiazolyl or C( .dbd. O)NR6, |
| 07/21/2005 | US20050159416 Substituted urea derivatives activate the cardiac sarcomere by potentiating cardiac myosin; systolic heart failure including congestive heart failure; 1-[3-(1-Acetyl-piperidin-3-yloxy)-5-fluoro-phenyl]-3-(6-methoxy-pyridin-3-yl)-urea |
| 07/21/2005 | CA2552726A1 Cathepsin cysteine protease inhibitors |
| 07/21/2005 | CA2551346A1 N-substituted piperidine and piperazine derivatives |
| 07/21/2005 | CA2549330A1 Calcitonin gene related peptide receptor antagonists |
| 07/21/2005 | CA2549089A1 Opioid receptor antagonists |
| 07/20/2005 | EP1554274A1 1-acyl-pyrrolidine derivatives for the treatment of viral infections |
| 07/20/2005 | EP1554273A1 Antimicrobial 1-aryl dihydropyridone compounds |
| 07/20/2005 | EP1554272A1 Benzimidazoles and benzothiazoles as inhibitors of map kinase |
| 07/20/2005 | EP1554269A1 Imidazoles, oxazoles and thiazoles with protein kinase inhibiting activities |
| 07/20/2005 | EP1554264A2 Medicinal arylethanolamine compounds |
| 07/20/2005 | EP1554258A1 5-substituted-2-arylpyrazines as modulators of crf receptors |
| 07/20/2005 | EP1554257A1 Quinazolinone derivatives useful as anti-hyperalgesic agents |
| 07/20/2005 | EP1554254A1 Novel compounds |
| 07/20/2005 | EP1554245A1 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 07/20/2005 | EP1553949A2 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 07/20/2005 | EP1553947A2 Quinazolinones and derivatives thereof as factor xa inhibitors |
| 07/20/2005 | EP1553931A1 Compounds, compositions, and methods |
| 07/20/2005 | EP1379511B1 DIHYDRO-BENZO (b) (1, 4) DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II |
| 07/20/2005 | EP1286673B8 Ligands of integrin receptors |
| 07/20/2005 | EP1272484B1 Benzoamide piperidine compounds as substance p antagonists |
| 07/20/2005 | EP1189583B1 Indole derivatives |
| 07/20/2005 | EP1175402B1 Piperidine derivatives useful as ccr5 antagonists |
| 07/20/2005 | EP1175401B1 Piperazine derivatives useful as ccr5 antagonists |
| 07/20/2005 | CN1642950A 6-(4-substituted-anilino)pyrimidine derivatives, method for the preparation thereof and antiviral pharmaceutical composition comprising the same |
| 07/20/2005 | CN1642949A Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterial, related compositions and methods |
| 07/20/2005 | CN1642948A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642944A (3Z) -3-(2, 3-dihydro-1H-ylidene)-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 07/20/2005 | CN1642938A New compounds |
| 07/20/2005 | CN1642931A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642928A Process for the preparation of morpholine derivatives and intermediates therefore |
| 07/20/2005 | CN1642927A Cyclic amides |
| 07/20/2005 | CN1642925A Novel tetrazole derivative useful as herbicides |
| 07/20/2005 | CN1642922A Substituted indazoles with anti-cancer activity |
| 07/20/2005 | CN1642919A Pyrazolines for use as pesticides |
| 07/20/2005 | CN1642917A Non-peptide GnRH antagonists |
| 07/20/2005 | CN1642915A Benzamide derivatives useful as histone deacetylase inhibitors |
| 07/20/2005 | CN1642912A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642911A Phthalimido derivatives as inhibitors of monoamine oxidase B |
| 07/20/2005 | CN1642910A Synthesis of indole thiazole compounds as ligands for the AH receptor |
| 07/20/2005 | CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642906A Novel arylamidine derivative or salt thereof |